Jabbour Reports Top Takeaways From ASH 2023 of Olverembatinib in CML and ALL
Season 10, Episode 2, Dec 28, 2023, 07:00 PM
Dr Jabbour discusses the activity and the utilization of olverembatinib in chronic myeloid leukemia and expanded upon the role that TKIs can play in the management of malignancies beyond chronic myeloid leukemia and acute lymphoblastic leukemia.